Browsing "1. College of Medicine (의과대학)" by Author : 1444

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 44 to 58 of 58

This table browses all dspace content
Issue DateTitleJournal Title
2023Palbociclib (P) plus tamoxifen (TAM) ± goserelin in women with hormone receptor-positive (HR+)/HER2-negative (HER2-) advanced breast cancer (ABC): Primary results of NCCH1607/PATHWAY, an Asian international double-blind randomized phase 3 trial.JOURNAL OF CLINICAL ONCOLOGY
2020Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
2020Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10) CANCERS
2021Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations INVESTIGATIONAL NEW DRUGS
2013Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerLUNG CANCER
2017Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancerEUROPEAN JOURNAL OF CANCER
2011Prevalence and associated factors of psychological distress among Korean cancer patientsGENERAL HOSPITAL PSYCHIATRY
2017Prevalence and prognostic implications of psychological distress in patients with gastric cancer BMC CANCER
2020Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting CANCER RESEARCH AND TREATMENT
2021Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer FRONTIERS IN ONCOLOGY
2021Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary PerspectiveANNALS OF SURGERY
2018The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea ControlCANCER NURSING
2012The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinomaCANCER CHEMOTHERAPY AND PHARMACOLOGY
2021Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2010Wernicke's encephalopathy in advanced gastric cancer CANCER RESEARCH AND TREATMENT
1

Browse

Links